leadf
logo-loader
viewNovamind Inc

Novamind looks to scale mental health clinics and clinical sites with shift in psychedelics policies

Novamind Inc. (CSE:NM) CEO Yaron Conforti tells Proactive the Toronto-based group is looking to scale its mental health clinics and its clinical research sites as policy around psychedelic drugs shifts in the US and around the world. Conforti says part of the group's plan when it chose to go public, was to expand its reach into the US. The group currently has mental health clinics in various locations in Utah, and offers its clients access to ketamine therapies.

Quick facts: Novamind Inc

Price: 1.56 CAD

CSE:NM
Market: CSE
Market Cap: $62.71 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Danakali 're-energised' and focused on getting the Colluli SOP project up...

Danakali Ltd's (ASX:DNK) (OTCMKTS:SBMSF) (LON:DNK) (FRA:SO3) Seamus Cornelius caught up with Proactive's Andrew Scott soon after announcing a restructure of its board. He's confident that their unique Colluli Sulphate of Potash (SOP) Project in Eritrea, Africa, is set to become a global game...

7 hours, 36 minutes ago

2 min read